Drug Type Small molecule drug |
Synonyms Bismuth subgallate, basic bismuth 3,4,5-trihydroxybenzoate, gallic acid bismuth basic salt + [1] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists), Nav1.8 blockers(Sodium channel protein type X alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date TR (01 Aug 1997), |
Regulation- |
Molecular FormulaC7H5BiO6 |
InChIKeyJAONZGLTYYUPCT-UHFFFAOYSA-K |
CAS Registry99-26-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Hydrocortisone/Benzocaine/Bismuth Subgallate/Benzalkonium Chloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Fissure in Ano | TR | 01 Aug 1997 | |
Hemorrhoids | TR | 01 Aug 1997 |
Not Applicable | - | wyhogwnepv(ptisjscdds) = gbcngwbxib acuhornfvs (pvcxgfkbye ) | - | 15 Apr 2010 |